Oncology

Audio Journal of Oncology Volume 16 Number 9

Source: European Breast Cancer Conference, Berlin, April 15-19 2008

Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam

Angel Rodriguez
Angel Rodriguez

In this edition:

1. Lapatinib: Targets Breast Cancer Stem Cells?

Angel Rodriguez, Baylor College, Houston

2. No Help Adding Neoadjuvant Capecitabine

Gunter von Minckwitz, German Breast Group, Neu-Isenberg

3. MRI Aids Breast Surgery Planning

David Martinez-Cecilia, University Hospital Reina Sofia, Córdoba

4. Aromatase Inhibitors: No Extra Heart Risk

Alain Monnier, Centre Hospitalier de Belfort, Montbéliard

5. NAB Paclitaxel For Metastatic Breast Cancer?

William Gradishar, Northwestern University, Chicago

Peter Goodwin and Sara Freeman interview conference speakers in Berlin regarding lapatinib’s apparent effect on breast cancer “stem cells”; the lack of additional benefit from adding capecitabine to standard neoadjuvant chemotherapy; evidence that MRI improves surgical planning for breast cancer; news that aromatase inhibitors do not add to cardiovascular risk when used in adjuvant therapy instead of tamoxifen; and (from a satellite symposium) an assessment of the role of nanoparticle albumin-bound paclitaxel in therapy for metastatic breast cancer.

Download this interview

Similar Interviews

  • Hematologic Malignancy
  • Audio Journal of Hematologic Malignancy Volume 2 Number 1 Reporting from: American Society of Hematology Meeting, Philadelphia, December 6-10,

  • Audio Journal of Oncology Volume 16 Number 11
  • Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Sarah Maxwell and Peter Goodwin report from:

  • Audio Journal of Oncology Volume 16 Number 10
  • Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Commenting Expert: Michael Untch, HELIOS Klinikum, Berlin In

    Post a comment